Psyence BioMed delays reverse stock split effective date announcement, Nasdaq: PBM stock impacted.
On January 20, 2026, Psyence Biomedical Ltd. (Nasdaq: PBM) disclosed the decision to delay the planned effective date of its reverse stock split for its common stock. The company, referred to as Psyence BioMed, opted to postpone this action affecting its issued and outstanding common stock shares.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments